The Amoxicillin for Oral Suspension, cataloged under National Stock Number 6505-01-066-4195, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-066-4195 |
| Primary Part Number | NDC00093-4155-80 |
| Item Name | Amoxicillin for Oral Suspension |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 150.000 MILLILITERS AFTER RECONSTITUTION |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Physical Form | POWDER |
| Active Medicament Medicinal Strength | 250.000 MILLIGRAMS AMOXICILLIN PER 5 MILLILITERS OF RECONSTITUTED SUSPENSION |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00093-4155-80 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC65862-0707-55 PRIMARY | Aurobindo Pharma Usa Inc Dba Aurobindo Pharma U S a Inc (USA) |
| NDC00781-6041-55 PRIMARY | Sandoz Inc. (USA) |
NSN 6505-01-066-4195 is a Amoxicillin for Oral Suspension, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-066-4195 has 3 manufacturer part numbers on file: NDC00093-4155-80 (Teva Pharmaceuticals Usa, Inc.), NDC65862-0707-55 (Aurobindo Pharma Usa Inc Dba Aurobindo Pharma U S a Inc), NDC00781-6041-55 (Sandoz Inc.).
Key specifications for NDC00093-4155-80: Primary Container Content Quantity: 150.000 MILLILITERS AFTER RECONSTITUTION; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Physical Form: POWDER. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.